Literature DB >> 24936885

International psychopharmacology algorithm project: algorithms in psychopharmacology.

K Jobson.   

Abstract

Year:  1997        PMID： 24936885     DOI： 10.3109/13651509709024748

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN： 1365-1501            Impact factor:   1.812


× No keyword cloud information.
  5 in total

1.  Guidelines for treatment of bipolar disorder.

Authors:  E B Dennehy
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

Review 2.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 3.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

4.  Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta; Melina Siamouli; Marc Valenti; Stamatia Magiria; Timucin Oral; David Fresno; Panteleimon Giannakopoulos; George S Kaprinis
Journal:  Ann Gen Psychiatry       Date:  2007-10-09       Impact factor: 3.455

Review 5.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.

Authors:  Konstantinos N Fountoulakis; Heinz Grunze; Eduard Vieta; Allan Young; Lakshmi Yatham; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.